Pharmaceuticals, Biotechnology and Life Sciences
Total eligible patients in the US exceed 2 million.Treatment of SARS-CoV-2 infection in solid and hematologic cancer patients under active…
FLORHAM PARK, N.J., Oct. 16, 2024 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, today…
SAN FRANCISCO, Oct. 16, 2024 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted…
-Lexicon to receive an upfront payment of $25 million and the potential for contingent regulatory and commercial milestone paymentsTHE WOODLANDS,…
Event featuring David T. Ahn, MD from Hoag Medical Group and Jeff Ciaramita, MD from Mercy health system, along with managementGERMANTOWN, Md., Oct.…
WARREN, N.J., Oct. 16, 2024 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage…
SAN DIEGO, Oct. 16, 2024 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based…
RADNOR, Pa., Oct. 16, 2024 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today…
IRVINE, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) — Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, announced today that CEO…
In vitro data on SPR719 show low propensity for resistance development in NTM-PD MAC strains when administered as a single…